Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast CancerChunlong Zhao, Yu Zhang, Jin’ge Zhang et al.|Journal of Medicinal Chemistry|2023Cited by 24